Anfield Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$82.8K	Hold	71,377	–	–	0.03%	128
2025 Q1	$113K	Sell	71,377 -57,941	-45%	-$92.1K	0.04%	98
2024 Q4	$392K	Buy	129,318 +64,659	+100%	+$196K	0.14%	52
2024 Q3	$238K	Buy	64,659 +54,892	+562%	+$202K	0.09%	61
2024 Q2	$39.9K	Buy	+9,767	New	+$39.9K	0.02%	121